Effects of oral cysteine leukotriene receptor antagonist-montelukast on adenoid lymphoid tissue: a histopathological study under light microscope

Effects of oral cysteine leukotriene receptor antagonist-montelukast on adenoid lymphoid tissue: a histopathological study under light microscope

Background: Adenoidal hypertrophy (AH) is one of the most common causes of upper airway obstruction in children. Drug and surgical treatment are the typical treatment of AH. The study on the inflammatory mechanism of AH in children provides a new idea for preoperative intervention and non-surgical t...

Full description

Bibliographic Details
Main Authors:	Zhengying Wang, Xiuling Wu, Jinghong Liu, Yu Wang, Yue Zhang, Yan Wu, Yingxue Kang, Ronghai Zhang, Jin Li, Delong Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Pharmacology
Subjects:	adenoid hypertrophy cysteine leukotriene receptor antagonist montelukast histopathological lymphocytes
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1285647/full

Similar Items

Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
by: Cátia F. Marques, et al.
Published: (2022-08-01)

Non-obvious effects of montelukast – leukotriene receptor blocker: frigoprotective and anticonvulsant properties
by: S.Yu. Shtrygol, et al.
Published: (2021-06-01)

Effect of Combination Montelukast and Nasal Mometasone on Childhood Adenoid Hypertrophy
by: Mohsen Jafari, et al.
Published: (2024-03-01)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
by: Johan Wallin, et al.
Published: (2021-05-01)

Effect of montelukast on leukotriene B4 metabolism in asthma
by: HU Yu, et al.
Published: (2023-05-01)

The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
by: Johanna Michael, et al.
Published: (2021-03-01)

Pediatric Asthma: Where Has Montelukast Gone?
by: Marco Maglione, et al.
Published: (2023-03-01)

Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium
by: Yuan Li, et al.
Published: (2024-01-01)

Cysteinyl Leukotriene Pathway and Cancer
by: Ming-Ju Tsai, et al.
Published: (2021-12-01)

The Efficacy of Montelukast Monotherapy in Moderate Persistent Asthmatic Children
by: Mahir Igde, et al.
Published: (2009-09-01)

Therapeutic Effect of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, on Japanese Patients with Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Montelukast and Acute Coronary Syndrome: The Endowed Drug
by: Basil Mohammed Alomair, et al.
Published: (2022-09-01)

Montelukast Use Decreases Cardiovascular Events in Asthmatics
by: Malvina Hoxha, et al.
Published: (2021-01-01)

Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats
by: Alper Otunctemur, et al.
Published: (2015-04-01)

Expert opinion on montelukast and acebrophylline combination in the management of asthma
by: N H Krishna, et al.
Published: (2021-01-01)

The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia
by: Sang Bum Kim, et al.
Published: (2015-09-01)

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
by: Eman El-Khateeb, et al.
Published: (2023-04-01)

Churg-Strauss Syndrome associated with montelukast: Three Case Reports
by: Fatih Yildiz, et al.
Published: (2014-04-01)

Theophylline and leukotriene modifiers: Is there any compelling role in COPD?
by: Abhijeet Singh, et al.
Published: (2020-01-01)

Montelukast and Coronavirus Disease 2019: A Scoping Review
by: Niusha Sharifinejad, et al.
Published: (2021-08-01)

Anti-leukotriene agents in modern therapy of bronchial asthma in children
by: Yu. L. Mizernitskiy
Published: (2020-03-01)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta Alessandra, et al.
Published: (2012-07-01)

Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men
by: Renata Esposito, et al.
Published: (2019-09-01)

Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified
by: Bjørn Grinde, et al.
Published: (2017-08-01)

A Double-Blind Non-inferiority Clinical Study of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Compared with Pranlukast in Patients with Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Cognitive Effects of Montelukast: A Pharmaco-EEG Study
by: Fabian Schwimmbeck, et al.
Published: (2021-04-01)

Montelukast ilişkili Churg Strauss Sendromu: Üç Olgu
by: Fatih YILDIZ, et al.
Published: (2014-07-01)

Evaluating the effect of montelukast tablets on respiratory complications in patients following blunt chest wall trauma: A double-blind, randomized clinical trial
by: Soleyman Heydari, et al.
Published: (2023-03-01)

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
by: Ludwig Aigner, et al.
Published: (2020-12-01)

Leukotriene Signaling as a Target in α-Synucleinopathies
by: Katharina Strempfl, et al.
Published: (2022-02-01)

Role of Leukotriene receptor antagonist Montelukast in the treatment of chronic urticaria: A hospital based study
by: Iffat Hassan, et al.
Published: (2012-01-01)

The role of leukotriene receptor blockers in the treatment of allergic rhinitis in combination with chronic rhinosinusitis with nasal polyps
by: E. L. Savlevich, et al.
Published: (2022-05-01)

Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity
by: Margherita Tassan Mazzocco, et al.
Published: (2023-02-01)

Upregulation of Leukotriene Receptors in Gastric Cancer
by: Daniel Schubert, et al.
Published: (2011-08-01)

Editorial: Insights in inflammation pharmacology: 2022
by: Paola Patrignani, et al.
Published: (2023-06-01)

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
by: Li Q, et al.
Published: (2019-12-01)

ROLE OF MONTELUKAST IN PREVENTING RELAPSE IN CHILDHOOD IDIOPATHIC NEPHROTIC SYNDROME: A QUASI-EXPERIMENTAL STUDY
by: Hashim Raza, et al.
Published: (2021-06-01)

Effects of oral montelukast on airway function in acute asthma: A randomized trial
by: Alisha Chaudhury, et al.
Published: (2017-01-01)

NOVEL PROTECTIVE ROLE OF MONTELUKAST AGAINST ASPIRIN INDUCED GASTRIC ULCERATION IN RABBITS - MONTELUKAST; A REVOLUTIONARY ASPECT
by: Syeda Urooj Zaidi, et al.
Published: (2020-09-01)

Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis
by: Erkan Yildiz, et al.
Published: (2019-12-01)